Skip to main content
. 2021 Mar 27;36(4):427–439. doi: 10.1007/s12291-021-00968-z

Table 2.

Types of vaccines in clinical trials

Platform Candidate vaccine number (%) n = 64
Protein subunit 19 (30%)
Inactivated virus 10 (16%)
RNA 7 (11%)
Viral Vector (replicating) 4 (6%)
Virus like particle 2 (3%)
Viral vector + Antigen presenting cell 2 (3%)
Live attenuated virus 1 (2%)
Viral vector + Antigen presenting cell 1 (2%)